These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


524 related items for PubMed ID: 33660264

  • 1. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
    Xie X, Liu P, Gao L, Zhang X, Lan P, Bijol V, Lv J, Zhang H, Jin J.
    J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
    [Abstract] [Full Text] [Related]

  • 2. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation.
    van Dixhoorn MG, Sato T, Muizert Y, van Gijlswijk-Janssen DJ, De Heer E, Daha MR.
    Kidney Int; 2000 Jul; 58(1):90-9. PubMed ID: 10886553
    [Abstract] [Full Text] [Related]

  • 3. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 4. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R, Ståhl AL, Olin AI, Kristoffersson AC, Rebetz J, Novak J, Lindahl G, Karpman D.
    J Immunol; 2014 Jul 01; 193(1):317-26. PubMed ID: 24850720
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J.
    J Autoimmun; 2021 Mar 01; 118():102593. PubMed ID: 33508637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME.
    J Clin Invest; 1990 Sep 01; 86(3):715-22. PubMed ID: 2203821
    [Abstract] [Full Text] [Related]

  • 10. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 01; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A, Kawanishi K, Horita S, Koike J, Honda K, Ochi A, Komoda M, Tanaka Y, Unagami K, Okumi M, Shimizu T, Ishida H, Tanabe K, Nagashima Y, Nitta K.
    Nephrology (Carlton); 2016 Jul 01; 21 Suppl 1():48-52. PubMed ID: 26971743
    [Abstract] [Full Text] [Related]

  • 13. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V, Esparza AR, Cavallo T, Rifai A.
    Lab Invest; 1991 Apr 01; 64(4):508-19. PubMed ID: 2016857
    [Abstract] [Full Text] [Related]

  • 14. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy.
    Wu J, Hu Z, Wang Y, Hu D, Yang Q, Li Y, Dai W, Zhu F, Yang J, Wang M, Zhu H, Liu L, He X, Han M, Yao Y, Pei G, Zeng R, Xu G.
    Histopathology; 2021 May 01; 78(6):882-895. PubMed ID: 33336446
    [Abstract] [Full Text] [Related]

  • 15. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
    Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L.
    J Am Soc Nephrol; 2016 Sep 01; 27(9):2622-9. PubMed ID: 26850635
    [Abstract] [Full Text] [Related]

  • 16. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC.
    J Nephrol; 2016 Feb 01; 29(1):5-11. PubMed ID: 26572664
    [Abstract] [Full Text] [Related]

  • 17. Combined administration of IgA and IgG anti-Thy-1 antibodies enhances renal inflammation in rats.
    Van Dixhoorn MG, Sato T, Muizert Y, Van Gijlswijk-Janssen DJ, de Heer E, Daha MR.
    Kidney Int; 1999 Jun 01; 55(6):2299-309. PubMed ID: 10354278
    [Abstract] [Full Text] [Related]

  • 18. Murine Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y.
    Semin Nephrol; 2018 Sep 01; 38(5):513-520. PubMed ID: 30177023
    [Abstract] [Full Text] [Related]

  • 19. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
    Tamouza H, Vende F, Tiwari M, Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC, Moura IC.
    Contrib Nephrol; 2007 Sep 01; 157():144-7. PubMed ID: 17495453
    [Abstract] [Full Text] [Related]

  • 20. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB.
    Nat Med; 1999 Sep 01; 5(9):1018-25. PubMed ID: 10470078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.